Dozens of documentaries reviewed

Alexion Pharmaceuticals, Inc. today announced financial results for the three months ended March 31, 2012. The Company reported net product sales of Soliris® of $244.7 million, an increase of 47 percent from the same period in 2011.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from a retrospective subanalysis of the Phase 2 PROVE 2 study that showed that 100 percent (12/12) of patients with the IL28B CC genotype who were new to treatment achieved a viral…

Vertex Pharmaceuticals Incorporated today announced data from a retrospective subanalysis of the Phase 2 PROVE 2 study that showed that 100 percent of patients with the IL28B CC genotype who were new to treatment achieved a viral cure with a total of 1…

NEW YORK, April 18, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: The 2012 US Infectious Disease Testing Market http://www.reportlinker.com/p0368579/The-2012-US-Infectious-Disease-Testi…

NEW YORK, April 16, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global Organ and Tissue Transplantation Industry http://www.reportlinker.com/p080465/Global-Organ-and-Tissue-Transplant…

As an analyst who spends a great deal of time researching biotech and pharma companies, I'm well aware of the challenges facing the drug industry in the US today.